PMID: 2500880Jul 15, 1989Paper

Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation

Annals of Internal Medicine
R H Falk

Abstract

Flecainide acetate has a recognized proarrhythmic effect in patients treated for ventricular tachycardia. Three patients developed severe ventricular arrhythmias while taking flecainide for atrial fibrillation. Patient 1 had normal ventricular function and idiopathic atrial fibrillation. Treadmill exercise tests during digoxin therapy showed no ventricular arrhythmia; however, during flecainide therapy the patient developed ventricular flutter at his peak exercise level that required cardioversion. Patient 2 had normal ventricular function and a prosthetic mitral valve. During therapy with flecainide, 150 mg twice daily, he had an episode of sustained ventricular tachycardia, also at his peak exercise level. Patient 3 had paroxysmal atrial fibrillation and hypertrophic cardiomyopathy but no previous ventricular arrhythmia. She died suddenly within 10 days of starting flecainide therapy. Judged from previous findings none of these patients was considered at high risk for proarrhythmia. These cases suggest a possible relation between vigorous exercise, atrial fibrillation, and the proarrhythmic properties of flecainide and indicate the limitations of classifying patients as "high-risk" or "low-risk" for proarrhythmic complication...Continue Reading

Citations

May 1, 1993·Clinical Cardiology·L GullestadJ Kjekshus
Oct 1, 1996·Clinical Cardiology·M Reardon, A J Camm
Sep 1, 1994·Journal of Clinical Pharmacology·J L BaumanR J Hariman
Jun 1, 1991·Cardiovascular Drugs and Therapy·R Bolognesi
Mar 1, 1990·Journal of the American College of Cardiology·R A Bauernfeind, W J Welch
Dec 1, 1991·Journal of the American College of Cardiology·J L Anderson
Jan 25, 1996·The American Journal of Cardiology·S M Sopher, A J Camm
Nov 11, 1998·The American Journal of Cardiology·P L Friedman, W G Stevenson
Oct 3, 1999·Progress in Cardiovascular Diseases·S L Pinski, M E Helguera
May 1, 1991·Journal of the American College of Cardiology·H L WeinerE L Pritchett
Oct 31, 2000·Critical Care Medicine·G M Chaudhry, C I Haffajee
Aug 13, 1999·Journal of Cardiovascular Pharmacology·P S FischbachB R Lucchesi
Apr 18, 2007·Journal of Cardiovascular Pharmacology·Klaus J WirthHeinz Gögelein
Jun 1, 1990·Pacing and Clinical Electrophysiology : PACE·M N WisemanA W Nathan
Oct 1, 1992·Pacing and Clinical Electrophysiology : PACE·J NazariR F Kehoe
Sep 1, 1994·Pacing and Clinical Electrophysiology : PACE·D N RandazzoS L Winters
Apr 1, 1997·Pacing and Clinical Electrophysiology : PACE·D KatritsisA J Camm
Nov 14, 1997·Pacing and Clinical Electrophysiology : PACE·A CapucciD Aschieri
Nov 1, 1994·Journal of Cardiovascular Electrophysiology·R H Falk, R I Fogel
Oct 1, 1995·Journal of Cardiovascular Electrophysiology·E M Antman
Aug 1, 1995·Journal of Cardiovascular Electrophysiology·R E Hillsley, J M Wharton
Nov 18, 1997·Journal of Cardiovascular Electrophysiology·L I Ganz, E M Antman
Apr 21, 1999·Journal of Cardiovascular Electrophysiology·R J MyerburgA Castellanos
Sep 30, 1989·BMJ : British Medical Journal·C GarrattA J Camm
Oct 1, 1993·British Heart Journal·J C Cowan
Jun 15, 2005·Psychosomatic Medicine·Steven P Roose, Marissa Miyazaki
Mar 1, 2002·Herzschrittmachertherapie & Elektrophysiologie·Jörg MittagHelmut U Klein
Oct 16, 2015·Expert Review of Clinical Pharmacology·Konstantinos VlachosKonstantinos P Letsas
May 1, 1994·Pacing and Clinical Electrophysiology : PACE·M A Fromer
Nov 1, 1996·Cardiology Clinics·F Jung, J P DiMarco
Oct 30, 2010·Pacing and Clinical Electrophysiology : PACE·Han Sang KimSung Soon Kim
Oct 12, 2013·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Bhaskar BhardwajStavros Stavrakis
Oct 15, 1995·The American Journal of Cardiology·C RostagnoG Gensini
Jan 1, 1990·The American Journal of Cardiology·S C Vlay
Jul 1, 1993·American Heart Journal·C M BlattT B Graboys

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.